Anna E. Vilgelm, M.D., Ph.D.
Research Assistant Professor in Cancer Biology
Vanderbilt-Ingram Cancer Center
432 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232-6307
Fax: (615) 322-0375
The main focus of my research program is on design and preclinical evaluation of novel therapeutic strategies for treatment of metastatic cancers, including breast cancer and melanoma. The approach is to use clinically relevant tumor models such as patient-derived xenografts (PDXs), as well as humanized and immunocompetent transgenic tumor-bearing mice to design rational combinations of novel and emerging cancer therapies, including tumor-targeting and immune-stimulating therapies, to ultimately improve treatment outcomes for cancer patients.
- Ph.D., Russian Academy of Sciences, Moscow, Russia (2011)
- M.D., Russian State Medical University, Moscow, Russia (2005)
- M.Sc., Russian State Medical University, Moscow, Russia (2005)